Documentos relacionados

1. Timing of prescription of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients hospitalized for acute heart failure with reduced/mildly reduced ejection fraction: a retrospective analysis.
2. Perioperative Renin-Angiotensin System Inhibitors Improve Major Outcomes of Heart Failure Patients Undergoing Cardiac Surgery: A Propensity-Adjusted Cohort Study.
3. Possible pathway for heart failure with preserved ejection fraction prevention and treatment: the angiotensin-converting enzyme inhibitor effect on endothelial function in comorbid patients.
4. Impact of different angiotensin-converting inhibitors on outcomes of post-myocardial infarction patients.
5. Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial.
6. Validation and derivation of short-term prognostic risk score in acute decompensated heart failure in China.
7. Survival Association of Angiotensin Inhibitors in Heart Failure With Reduced Ejection Fraction: Comparisons Using Self-Identified Race and Genomic Ancestry.
8. Benefits and adverse effects of ACE inhibitors in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis.
9. Network meta-analysis of medical therapy efficacy in more than 90,000 patients with heart failure and reduced ejection fraction.
10. Management of heart failure in patients with kidney disease-updates from the 2021 ESC guidelines.